1. Home
  2. BUR vs AVDL Comparison

BUR vs AVDL Comparison

Compare BUR & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burford Capital Limited

BUR

Burford Capital Limited

HOLD

Current Price

$8.92

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.39

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUR
AVDL
Founded
2009
2015
Country
Guernsey
Ireland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
BUR
AVDL
Price
$8.92
$21.39
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$18.00
$18.38
AVG Volume (30 Days)
2.4M
2.8M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
0.40
N/A
Revenue
$466,134,000.00
$248,517,000.00
Revenue This Year
$13.60
$65.47
Revenue Next Year
$10.53
$30.88
P/E Ratio
$22.65
N/A
Revenue Growth
N/A
79.88
52 Week Low
$8.19
$6.38
52 Week High
$15.73
$23.57

Technical Indicators

Market Signals
Indicator
BUR
AVDL
Relative Strength Index (RSI) 40.85 59.01
Support Level $9.23 $21.34
Resistance Level $9.30 $21.55
Average True Range (ATR) 0.28 0.24
MACD 0.04 -0.24
Stochastic Oscillator 10.87 11.81

Price Performance

Historical Comparison
BUR
AVDL

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: